Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mettler-Toledo InternationalMTD -1.88%92 Cyclically Adjusted PB Ratio is 122.32 as of Jul. 18, 2026, which is 141% above its 10-year median of 50.73. GuruFocus rates MTD with a GF Score™ of 92/100 and a GF Value™ of $1,436.24 (Fairly Valued). The stock has 1 warning sign investors should review. Among 136 Medical Diagnostics & Research companies, Mettler-Toledo International ranks worse than 100% on this metric.
The historical rank and industry rank for Mettler-Toledo International's Cyclically Adjusted PB Ratio or its related term are showing as below:
MTD'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 16.33 Med: 50.73 Max: 132.01
Current: 122.35
During the past years, Mettler-Toledo International's highest Cyclically Adjusted PB Ratio was 132.01. The lowest was 16.33. And the median was 50.73.
MTD's Cyclically Adjusted PB Ratio is ranked worse than 100% of 136
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.915
vs MTD: 122.35
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Mettler-Toledo International's adjusted book value per share data for the three months ended in Mar. 2026 was $-2.073. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $10.71 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Mettler-Toledo International (NYSE:MTD) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Mettler-Toledo International Cyclically Adjusted PB Ratio Related Terms
Mettler-Toledo International Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International Cyclically Adjusted PB Ratio Chart
MTD vs ILMN, DGX, LH: Cyclically Adjusted PB Ratio Comparison
For the Diagnostics & Research subindustry, Mettler-Toledo International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's Cyclically Adjusted PB Ratio falls into.
Mettler-Toledo International Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 122.32 mean?
Mettler-Toledo International (MTD) has a Cyclically Adjusted PB Ratio of 122.32 as of Jul. 18, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Mettler-Toledo International and its competitors. This is 141% above median its historical median of 50.73. Over the past decade, Mettler-Toledo International's Cyclically Adjusted PB Ratio has ranged from 16.33 to 132.01. According to the industry distribution chart, Mettler-Toledo International ranks #136 out of 136 companies in the Medical Diagnostics & Research industry.
Is Mettler-Toledo International's Cyclically Adjusted PB Ratio too high?
Mettler-Toledo International's current Cyclically Adjusted PB Ratio of 122.32 is 141% above median its 10-year median of 50.73. Over the past 10 years, this metric has ranged from a low of 16.33 to a high of 132.01. The Medical Diagnostics & Research industry median Cyclically Adjusted PB Ratio is 1.92. Mettler-Toledo International's value of 122.32 is 6287.5% above this industry median. Based on the distribution chart, Mettler-Toledo International ranks #136 out of 136 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Mettler-Toledo International has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's Cyclically Adjusted PB Ratio compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #136 out of 136 companies for Cyclically Adjusted PB Ratio. This places Mettler-Toledo International in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.92. Mettler-Toledo International's value of 122.32 is 6287.5% above this benchmark. Historically, Mettler-Toledo International's own Cyclically Adjusted PB Ratio has ranged from 16.33 to 132.01 over the past decade. While the company's 10-year median is 50.73 vs. the industry median of 1.92, Mettler-Toledo International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Diagnostics & Research company?
The median Cyclically Adjusted PB Ratio among Medical Diagnostics & Research companies is 1.92, based on 136 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mettler-Toledo International's current Cyclically Adjusted PB Ratio of 122.32 is 6287.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median Cyclically Adjusted PB Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current Cyclically Adjusted PB Ratio is 122.32, which is 141% above median its own 10-year median of 50.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (MTD) is currently considered Fairly Valued. The stock's GF Value™ is $1,436.24, compared to a current price of $1,310.02 — trading 8.8% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 122.32, which is 141% above median its 10-year median of 50.73 and 6287.5% above the Medical Diagnostics & Research industry median of 1.92. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Mettler-Toledo International (MTD), the current Cyclically Adjusted PB Ratio is 122.32 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (MTD) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of $1,310.02 is trading 8.8% below its estimated GF Value™ of $1,436.24.
GuruFocus considers Mettler-Toledo International to be Fairly Valued.
Key valuation signals for MTD:
Cyclically Adjusted PB Ratio: 122.32 (141% above median its 10-year median of 50.73)
GF Value™: $1,436.24 vs. price of $1,310.02 (8.8% below fair value)
Industry Position: 6287.5% above the Medical Diagnostics & Research median (#136 of 136)
No single metric tells the full story. See the MTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for MTD
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTD has been successfully added to your 
